Chemical Structure (Bortezomib 01)
Bortezomib Injection, Powder, Lyophilized, For Solution
Product Images NDC 0409-1700
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Bortezomib (NDC 0409-1700). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Bortezomib 02)
This appears to be a chart displaying data related to patients in a medical or clinical study. The chart shows two groups of patients labeled as BMP and MP, and lists the number of patients remaining over time. It also includes a p-value from a log-rank test. However, without more context or information, it is difficult to provide a more specific description or interpretation.*
Figure 2 (Bortezomib 03)
Figure 3 (Bortezomib 04)
Figure 4 (Bortezomib 05)
This text seems to be presenting data related to the drugs Bortezomib and Dexamethasone. The numbers in the table appear to represent the number of "patients remaining" after a certain time point for each drug. However, without additional context or information it is difficult to provide a more detailed description or interpretation of the data.*
Figure 5 (Bortezomib 06)
Figure 6 (Bortezomib 07)
Logo (Bortezomib 08)
Principal Display Panel (3.5 mg Vial Label)
This is a description of a medication with NDC code 0409-1700-01. The contents of the medication include 3.5 mg of bortezomib and 35 mg of mannitol. The medication needs to be stored at a temperature between 20-25°C and needs to be protected from light. The medication is a cytotoxic agent. The packaging includes a single-dose vial and an area for batch detail and a 2D barcode. It is manufactured by Hospira.*
Principal Display Panel (3.5 mg Vial Carton)
This is a description of a medication called Bortezomib which is in a Single-Dose Vial containing 3.5 mg Lyophilized powder to be used for Intravenous or Subcutaneous Administration. The medication is stored in a temperature range of 20-25 degrees Celsius and should be protected from light. Additionally, the container should be discarded after a single use. The package contains Dosage Information, and Reconstitution Information is provided on the back of the container. The medication is manufactured by Hospira, and is Made In India.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
